NRSN icon

NeuroSense Therapeutics

13 hedge funds and large institutions have $266K invested in NeuroSense Therapeutics in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$105K
2 +$37.6K
3 +$32.1K
4
Pathstone Holdings
Pathstone Holdings
New Jersey
+$17.4K
5
UBS Group
UBS Group
Switzerland
+$17.1K

Top Sellers

1 -$83K
2 -$81.5K
3 -$1K